Introduction
Regulatory Foxp3 + CD4 + T cells (Tregs) are key controllers of immune homeostasis. They maintain immune tolerance, thus preventing autoimmunity or excessive inflammation [1, 2] . They are present in almost all tissues, even under homeostatic conditions, and regulate a variety of innate and adaptive immune cells [3, 4] . Various mechanisms mediating Treg functions have been described. These include direct suppression or cytolysis of target cells, repression of APC maturation and function as well as secretion and activation of anti-inflammatory cytokines such as IL-10 and TGFβ [5, 6] . Consequently, Tregs form a heterogeneous population displaying diverse migratory properties and immunomodulatory effects.
A minor fraction of Tregs in the circulation and lymphatic organs exhibits an activated effector/memory T cell phenotype similar to conventional T cells, thus termed effector Tregs. These Tregs are assumed to have encountered antigen more recently and preferentially reside in non-lymphoid tissues (NLT) [7] . Several surface markers distinguishing effector Tregs have been identified so far, including αE integrin (CD103) which marks a subset of highly suppressive, rapidly activated Tregs that preferentially resides in NLT [8] [9] [10] . A similar phenotype is observed in KLRG1-expressing Tregs that accumulate in the lung in a model of airway inflammation, accompanied by increased levels of CD44, CD69, CD25, CTLA-4 and a downregulation of CD62L [11, 12] . In general, effector Tregs display classical T cell activation markers, like CD44
hi and CD62L lo , along with molecules involved in Treg maintenance and function, such as Foxp3, CTLA-4, KLRG1, CD103 and ICOS and are thought to be highly suppressive. A growing body of evidence suggests that the acquisition of an effector-like phenotype does not mark the end point of Treg differentiation. Instead, further diversification comparable to conventional T cells may occur [13] [14] [15] [16] . Notably, the Th2 lineage-specifying transcription factor GATA-3 can be upregulated in Tregs upon encounter of antigen and IL-2 [17, 18] . In Th2 cells, GATA-3 induces transcription of the Il1rl1 gene, encoding ST2, the receptor for the alarmin IL-33 [19] . Recently, it was shown that ST2 is also expressed on a subset of Tregs in a GATA-3-dependent manner [20] . Additional studies revealed that systemic administration of IL-33 increased the number of total and ST2 + Tregs resulting in a delay of graft-versus-host disease and amelioration of colitis [21] [22] [23] . Moreover, in a setting of acute inflammation, IL-33 signals are essential for the accumulation of ST2 + Tregs in mucosal tissue and the stability of the Treg phenotype [20] . Yet, ST2 + Tregs are present in several organs even under homeostatic conditions [24] , but their phenotype and suppressive capacity at steady-state remain ill defined.
Here we report that ST2 + Tregs are highly activated effector Tregs that preferentially accumulate in NLT. They exhibit a Th2-like phenotype with elevated expression of GATA-3 and production of the Th2 cytokines IL-5 and IL-13, which can be further augmented by IL-33 signals. 
Material and Methods

Mice
Il33 -/- [25] , Il1rl1 -/- [26] and WT mice were bred on C57BL/6 background under SPF conditions at the Charité animal facility, Berlin. B6.Foxp3 hCD2 reporter mice [27] were crossed to 
T cell isolation for ex vivo characterization
Blood was drawn from animals before they were euthanized and perfused with PBS. Circulating lymphocytes were isolated by high density centrifugation using Histopaque (SigmaAldrich). Lungs were chopped, treated with 0.1U/ml Collagenase D (Roche), homogenized and applied to a Histopaque gradient. Spleen and LN were homogenized and splenic erythrocytes were lysed. Payer's patches were removed from the small intestine (SI). Colon and SI were cut and incubated in RPMI with 1mM DTT, 5mM EDTA, 5% FCS, homogenized and treated with 0.1U/ml Collagenase D. Single cell suspensions were applied to a 40/70% Percoll gradient.
Flow cytometric analysis and sorting
Samples were stained with antibodies against CD4 (GK1.5), CD25 (PC61), KLRG1 (2F1), Tregs were resuspended in 140-200μl of RPMI/10% FCS supplemented with 40ng/ml IL-2 with or without 30ng/ml IL-33. After 60-70h, supernatants were collected and cytokines were quantified by cytometric bead array (BD Pharmingen). For suppression assays, Tresp were labeled with CellTrace Violet or CFSE (Invitrogen). APCs were isolated from splenocytes by MACS using biotinylated anti-CD19 (1D3), antiCD11b (M1/70) and anti-CD11c (HL3) antibodies and anti-biotin microbeads (Miltenyi Biotec). IL-10 signaling was blocked by pre-incubation of Tresp with 50μg/ml anti-CD210/IL-10R (1B1.3a). TGFβ signaling was blocked using 10μM TGFβRI inhibitor in DMSO (SB431542, Merck Millipore) directly in culture. Control cells were treated with DMSO alone. The Treg: Tresp ratio was varied as indicated; twice as much APCs and 5μg/ml anti-CD3 antibody were added. Proliferation of Tresp was analyzed on day 4 by flow cytometry. The division index indicates the average number of divisions that a cell in the starting population has undergone. The relative division index was normalized to the corresponding untreated population.
mRNA isolation and quantification
RNA was isolated using the miRNeasy mini kit (Qiagen). Complementary DNA was synthesized using the Taqman Reverse Transcription Reagents (Life Technologies). Quantitative RT-PCR reactions were performed in duplicates using SYBR Select Master Mix (Life Technologies), respective primers (S1 Table) on a QuantStudio 7 real-time PCR system (Life Technologies). Data was normalized to Hprt endogenous control.
All reagents and kits were used at manufacturer's recommendation, if not stated otherwise. of Tregs were largely comparable in the spleen, peripheral lymph nodes (pLN) and lung of these mice (Fig 1B) . Although a significantly elevated frequency of splenic Tregs was detected 
Statistical analysis
ST2
+ Tregs preferentially home outside of secondary lymphoid organs
As distinct Treg subsets exhibit different migratory properties [29] , we compared the frequency of ST2 + Tregs in lymphoid (spleen, pLN) and non-lymphoid organs (lung, lamina propria of the small intestine (siLP) and colon (coLP)) of naive WT mice. While ST2 + Tregs were present in all organs, the highest frequency was found in non-lymphoid tissue (NLT), especially the lung (Fig 2A left) . In addition, the ST2-expressing Tregs at these sites expressed more ST2 on a per cell basis (Fig 2A right) , suggesting a preferential accumulation or development of highly ST2 + Tregs in the NLT. In agreement with these data, we found that ST2 + Tregs have an increased homing capacity to NLT based on their chemokine receptor expression ( Fig 2B) : First, CXCR3, involved in Treg recruitment to inflammatory sites [30] , was significantly higher expressed on ST2 + than ST2 − Tregs in all organs analyzed but the lung, suggesting an increased potential of ST2 + Tregs to home to those organs. However, expression was highest in the lung hinting towards a general requirement for lung-homing Tregs to express CXCR3. Second, CCR9 and α4β7 integrin are strong promoters of lymphocytic migration to the intestinal lamina propria [31] . Their expression was significantly higher on ST2 + than ST2 − Tregs found in the gut. Third, CCR4 has been implicated in enhanced migration of Tregs to the skin and lung to control local inflammation [10] . We found significantly higher CCR4 expression on ST2 + Tregs, suggesting preferential migration to these sites. Last, CCR7, a homing marker for secondary lymphoid organs [32, 33] , was significantly lower expressed on ST2 + than ST2 − Tregs.
Taken together, these results indicate that ST2 + Tregs accumulate in NLT, presumably facilitated by their distinct chemokine receptor and integrin expression pattern.
ST2 + Tregs display a highly activated phenotype
Next, we analyzed the expression of molecules associated with Treg function and activation on ST2 + and ST2 − Treg subsets. Both KLRG1 and CD103 have been described to be expressed on highly suppressive Tregs with the capacity to home to inflamed tissues [8] [9] [10] . Around 70% of splenic ST2 + Tregs expressed either one or both of these markers compared to only about 10% in the ST2 − Treg compartment. A similar distribution was observed in the pLN and lung ( Fig   2C) . These data suggest that the ST2 + Treg subset is largely comprised of highly differentiated and suppressive Tregs. To provide further evidence for the activated phenotype of ST2 + Tregs, two classical activation-associated surface molecules were assessed. While CD44 expression on Tregs is correlated with increased suppressive capacity [34] , the role of CD62L in Treg functionality is controversially discussed [35] [36] [37] . We found that ST2 + Tregs expressed high levels of CD44 and low levels of CD62L. Additionally, CTLA-4 is crucial for the suppressive function of Tregs [38] . Indeed, the frequency of CTLA-4 + Tregs was clearly increased in the ST2 + compartment, especially within lymphoid tissues (Fig 2D) . Moreover, we analyzed the expression of transcription factors in the ST2 + and ST2 − Treg subsets. Both the Treg-key regulator Foxp3
as well as the Th2-associated transcription factor GATA-3 were elevated in ST2 + Tregs ( Fig 2E   and S3A Fig) . In contrast, expression of T-bet, which can be induced in Tregs upon Th1-differentiating antigen encounter [13] , was not altered (S3B Fig) . Although specific to ST2 + Tregs, we found the expression of all of the aforementioned molecules to be independent of IL-33 (S3C and S3D Fig) .
At the mRNA level we could confirm a higher expression of Il1rl1 (ST2) and Foxp3 in ST2 + Tregs (Fig 2F) . Furthermore, the expression of two molecules associated with a highly activated and suppressive Treg phenotype, Icos and Prdm1 (Blimp1) [39, 40] , was significantly increased in the ST2 + compared to the ST2 − Treg subset. Next, we assessed the production of the antiinflammatory cytokine IL-10, whose expression in Tregs under homeostatic conditions is dependent on Blimp1 [40] and has been shown to confer Treg function [41] . In all organs, ST2 + Tregs displayed an increased capability to produce IL-10 when compared with ST2 − Tregs, with greatest differences detectable in the lung (Fig 2G) . Overall, these data suggest that the ST2 + Treg subset combines various characteristics of highly activated, differentiated and suppressive Tregs. proliferation at all ratios tested, ST2 + Tregs were considerably more suppressive (Fig 3A and   3B ). However, the addition of IL-33 had no beneficial effect on their suppressive capacity, but resulted in a selective increase of ST2 expression on ST2 + Tregs (Fig 3C) . Fig 4A-4C, 4E and 4F, data pooled from 2-3 independent experiments each performed with 2 replicates per condition. Fig 4D is representative of 2 independent experiments with at least 2 replicates per condition each. Bar graphs show the mean ± SD. Significance was tested using unpaired Student's t test. * p 0.05; ** p 0.01; *** p 0.001; non-significant (ns) p > 0.05. (Fig 4F) . Taken together, these data demonstrate that ST2 + Tregs employ a mechanism based on IL-10 and increased TGFβ production and activation to at least partially mediate their highly suppressive function.
Discussion
Recently, the expression of the IL-33 receptor ST2 was found on a subset of regulatory T cells [20-22, 24, 45] . However, their phenotype and tissue distribution under homeostatic conditions as well as the suppressive mechanism employed by these cells are still poorly understood.
Here we report that ST2 + Tregs display a Th2-biased effector Treg phenotype and strongly suppress naïve CD4 + T cell proliferation; an effect partially mediated by the anti-inflammatory cytokines IL-10 and TGFβ.
We observed that at steady-state, ST2 + Tregs preferentially accumulated at non-lymphoid tissues, such as the lung, the lamina propria of the small intestine and colon as well as the circulation. These findings are in agreement with previous data obtained in inflammatory settings that show an accumulation of ST2 + Tregs in the colon [20] , the lung and especially the visceral adipose tissue (VAT) [24, 46] . IL-33 is constitutively expressed in the nucleus of epithelial and endothelial cells and released upon necrotic cell death [47, 48] . However, under homeostatic conditions IL-33 release is very limited. Thus, our data demonstrate that signaling via the ST2 receptor is dispensable for the generation, maintenance and tissue accumulation of ST2 + Tregs.
Notably, VAT Tregs form an exception. This specialized, self-contained Treg subset, which also expresses the transcription factor PPARγ associated with adipocyte differentiation [49] , is highly dependent on the IL-33/ST2 axis for their stability and function in the VAT [24, 46, 50] . Regarding ST2 + Treg tissue migration, we identified chemokine receptors and integrins associated with NLT homing to be particularly highly expressed in the ST2 + Treg compartment, including CXCR3, CCR4, CCR6, CCR9, αE (CD103) and α4β7 integrin. Migration along the respective chemokine gradients could contribute to the positioning and retention of ST2 + Tregs at mucosal surfaces already under homeostatic conditions, leaving them in prime position to react to IL-33 danger signals. Low-level release of IL-33 due to constant minor cell damage may contribute to the augmented ST2 expression per cell observed at barrier tissues. We and others [20, 22, 24] demonstrated that ST2 + Tregs belong to a subset of highly activated effector Tregs based on their accumulation at NLT and expression of typical T cell activation markers and molecules involved in Treg maintenance and function. Recently, a subset of effector Tregs expressing the B cell-associated transcription factor Blimp1 was characterized [24, 40] . The authors report that Blimp1 is essential for the production of IL-10 by effector Tregs. Indeed, we found high expression of Prdm1 (Blimp1) in the ST2 + Treg compartment, paired with an increased IL-10 production capability in vitro and in vivo. Moreover, transcriptome analysis of Blimp1 + and Blimp1 -Tregs revealed a strong enrichment for ST2 in the Blimp1 + Treg subset [24] . Overall, these findings suggest a considerable overlap between the ST2 + and Blimp1 + effector Treg populations.
The Th2 lineage-defining transcription factor GATA-3 is a known inducer of ST2 expression in Tregs [20] . In line with previous reports [46] , we detected particularly high levels of GATA-3 in the ST2 + Treg compartment. Furthermore, these cells also secreted increased amounts of Th2-associated cytokines IL-5 and IL-13. In contrast to IL-4 which is produced neither by ST2 + nor ST2 -Tregs, GATA-3 has been reported to directly bind to the proximal promoters of IL-5 and IL-13 resulting in their expression [51] [52] [53] . However, the role of IL-10 and TGFβ in suppressing Tresp proliferation in vitro remains controversially discussed, with some reports claiming a contribution of these cytokines to the suppressive mechanism of Tregs [58, 59] and others not [60] [61] [62] . Yet, the amount of IL-10 and TGFβ produced by the studied Treg populations might strongly influence the observed effect of these cytokines on suppression. In summary, we demonstrate that ST2 expression identifies a highly activated, strongly suppressive Treg subset located in non-lymphoid tissues. The phenotype and function of these cells overlaps in many aspects with previously described effector Treg subsets. However, ST2 + Tregs stand out from these populations as they feature a Th2-biased phenotype already under homeostatic conditions. Additionally, these cells employ a mechanism based on IL-10 and increased TGFβ production and activation to mediate their enhanced suppressive function. Due to their specific capabilities, ST2 + Tregs may be suitable for targeted immunomodulatory therapies, e.g. to alleviate allergies or autoimmunity.
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